BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Free Report) saw a significant decline in short interest in October. As of October 15th, there was short interest totalling 100 shares, a decline of 80.0% from the September 30th total of 500 shares. Based on an average daily volume of 25,300 shares, the days-to-cover ratio is currently 0.0 days.
BetterLife Pharma Price Performance
Shares of OTCMKTS BETRF opened at $0.09 on Friday. The company has a market cap of $11.65 million, a price-to-earnings ratio of -3.00 and a beta of 1.23. BetterLife Pharma has a 12-month low of $0.03 and a 12-month high of $0.15. The firm’s 50-day simple moving average is $0.10 and its 200 day simple moving average is $0.09.
BetterLife Pharma (OTCMKTS:BETRF – Get Free Report) last released its quarterly earnings results on Wednesday, September 25th. The company reported ($0.01) EPS for the quarter.
BetterLife Pharma Company Profile
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.
Featured Stories
- Five stocks we like better than BetterLife Pharma
- What are earnings reports?
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- 3 Best Fintech Stocks for a Portfolio Boost
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
